Sermorelin represents a synthetic analogue of the biologically active portion of human growth hormone-releasing hormone, specifically corresponding to the amino-terminal 1-29 amino acid sequence of endogenous GHRH. The compound exhibits the molecular formula C149H246N44O42S with a molecular weight of 3357.933 g/mol and is catalogued in PubChem under CID 16132413. This 29-amino acid peptide is considered the shortest fully functional fragment of GHRH, retaining complete biological activity for growth hormone stimulation. Sermorelin functions through specific binding to growth hormone-releasing hormone receptors, mimicking the action of native GHRH in stimulating growth hormone secretion. The peptide activates adenylyl cyclase through G-protein coupled receptor signaling, leading to increased cyclic adenosine monophosphate (cAMP) levels and subsequent growth hormone release. For research use only.
Peptides
Sermorelin (10MG)
$99.99
Sermorelin is a synthetic 29-amino acid peptide corresponding to the active fragment of human growth hormone-releasing hormone (GHRH) with molecular formula C149H246N44O42S and molecular weight of 3357.933 g/mol. This peptide represents the shortest fully functional fragment of endogenous GHRH and demonstrates growth hormone releasing activity through GHRH receptor binding. Sermorelin is classified as a growth hormone secretagogue and is utilized in research investigating growth hormone regulation and pituitary function.
